fee (US:JVA) Newsfileยท2025-10-06 16:39Core Insights - Adia Nutrition Inc. has divested its Biolete coffee subsidiary to Cement Factory LLC while retaining an 18% ownership stake to maintain strategic alignment with Biolete's growth [1][4][5] - The divestiture allows Adia to focus on its core mission of expanding regenerative medicine and medical sales within the $5.3 trillion U.S. healthcare market [1][5][6] Company Strategy - The sale of Biolete, which specializes in organic protein and mushroom-infused coffee products, enables Adia to concentrate resources on scaling its medical division and enhancing its stem cell therapies [4][5] - Adia's CEO emphasized the transformative potential in medical treatments and regenerative therapies, indicating a strategic pivot towards these high-growth areas [5][6] Operational Developments - Adia has recently tripled its sales force and opened its first satellite clinic to expand access to regenerative treatments, reinforcing its commitment to community-based care [6] - The company has also improved its corporate governance by canceling over 25 million improperly issued shares, which enhances shareholder value and operational transparency [6] Future Outlook - Proceeds from the sale will be reinvested into the development of additional Adia Med clinics and R&D for next-generation therapies, positioning the company for future growth [7] - Cement Factory LLC, led by experienced entrepreneurs, is expected to drive Biolete's innovation and market expansion while collaborating with Adia on strategic initiatives [4][7]